{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-074822","form_type":"8-K","ticker":"GANX","cik":"0001819411","company_name":"Gain Therapeutics, Inc.","filed_at":"2024-06-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.347652+00:00","generated_at":"2026-06-01T02:16:02.774199+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Gain Therapeutics stockholders elect eight directors, ratify Ernst & Young as auditor at annual meeting","bullets":["All eight director nominees elected; broker non-votes of 5,183,098 shares on each nominee.","Vote totals for directors ranged from 4,308,578 (Hasler) to 6,581,651 (Richman).","Ernst & Young AG ratified as independent auditor for FY2024: 11,836,784 for, 119,833 against, 35,623 abstain.","Meeting held June 24, 2024 with quorum present."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-074822","json":"https://secwatch.observer/filing/0001104659-24-074822.json","markdown":"https://secwatch.observer/filing/0001104659-24-074822.md","text":"https://secwatch.observer/filing/0001104659-24-074822.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819411/000110465924074822/0001104659-24-074822-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819411/000110465924074822/tm2418205d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T02:16:02.774199+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}